Drug
Rofecoxib clinical trials
Also written Vioxx.
- studies test it
- 21
- open now
- 0
- in phase 3
- 14
- first study started
- 2001
How studies write it
Studies that test it under each name
Name
Brand
Development codes
Combined with it in one product
Studies by the year they started
19 studies that test it; most in 2003 (9)
| Year | Studies |
|---|---|
| 2001 | 3 |
| 2002 | 3 |
| 2003 | 9 |
| 2004 | 3 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 5
- Phase 3
- 14
- Phase 4
- 2
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 10 · Other 11
Merck Sharp & Dohme LLC (7) · National Institute of Dental and Craniofacial Research (NIDCR) (2) · Chinese University of Hong Kong (2) · National Cancer Institute, Naples (1) · Cancer Research Campaign Clinical Trials Centre (1) · Hospital Universitario Pedro Ernesto (1) · Johnson & Johnson Consumer and Personal Products Worldwide (1) · National Institute on Aging (NIA) (1)
Often tested with
Tested in the same studies.
Celecoxib (2) · Acetaminophen (2) · Naproxen (2) · Gemcitabine (1) · Aspirin (1) · Ibuprofen (1) · Bupivacaine (1) · Valdecoxib (1)
Studies
Open first, then newest update. How each study uses rofecoxib is read from its arms, and is right about nine times in ten.
Testing it · 21
- Study of Rofecoxib and Prolonged Constant Infusion of Gemcitabine in the Polychemotherapy Treatment of Advanced NSCLCCompletedPhase 2/3National Cancer Institute, NaplesNCT00385606Written as rofecoxib
- Rofecoxib Efficacy and Safety Evaluation Trial in Hemophilic ArthropathyTerminatedPhase 3Tremeau Pharmceuticals, Inc.NCT04684511Written as TRM-201 (Rofecoxib)
- A Double-blind, Double-dummy, Multicenter, Randomized Study of the Efficacy and Tolerability of Valdecoxib 40 mg Versus Rofecoxib 50 mg in Treating the Symptoms of Ankle SprainTerminatedPhase 4PfizerNCT00657449Written as rofecoxib
- Study of Vioxx and Radiation Therapy for Brainstem GliomaTerminatedPhase 1M.D. Anderson Cancer CenterNCT00038389Written as Vioxx
- Treatment With MK0966 for the Prevention of Prostate Cancer (0966-201)CompletedPhase 3Merck Sharp & Dohme LLCNCT00060476Written as rofecoxib
- A Study of Two Approved Drugs in Patients With Osteoarthritis (0966-220)(COMPLETED)CompletedPhase 3Merck Sharp & Dohme LLCNCT00092365Written as MK0966, rofecoxib
- A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-190)(COMPLETED)CompletedPhase 3Merck Sharp & Dohme LLCNCT00092339Written as MK0966, rofecoxib
- A Study of Two Approved Drugs in Patients With Osteoarthritis (0966-219)CompletedPhase 3Merck Sharp & Dohme LLCNCT00092352Written as MK0966, rofecoxib
- A Study of Two Approved Drugs in the Treatment of Post-Bunionectomy Surgery Pain (0966-234)(COMPLETED)CompletedPhase 3Merck Sharp & Dohme LLCNCT00092378Written as MK0966, rofecoxib
- A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-183)CompletedPhase 3Merck Sharp & Dohme LLCNCT00092326Written as MK0966, rofecoxib
- Rofecoxib After Surgery in Treating Patients With Stage II or Stage III Colorectal CancerCompletedPhase 3Cancer Research Campaign Clinical Trials CentreNCT00031863Written as rofecoxib
- CI(R)CA : Coumadin Interaction With Rofecoxib, Celecoxib and AcetaminophenCompletedNot applicableHospital Universitario Pedro ErnestoNCT01762891Written as Rofecoxib
- Coxib-inhibition of Duodenal Polyp Growth in FAPTerminatedPhase 2/3Oslo University HospitalNCT00844727Written as Rofecoxib
- A Safety Trial to Compare Different Analgesics in Combination With Low Dose Aspirin to Study Their Bleeding Properties and Their Effects on the StomachCompletedPhase 4Johnson & Johnson Consumer and Personal Products WorldwideNCT00261586Written as aspirin, acetaminophen, ibuprofen, naproxen, celecoxib, rofecoxib
- A Multicenter Trial of Rofecoxib and Naproxen in Alzheimer's Disease (NSAID Study)CompletedPhase 2/3National Institute on Aging (NIA)NCT00004845Written as Rofecoxib
- Rofecoxib and Bupivacaine to Prevent Pain After Third Molar (Wisdom Tooth) ExtractionCompletedPhase 2National Institute of Dental and Craniofacial Research (NIDCR)NCT00050362Written as Rofecoxib and Bupivacaine
- Rofecoxib to Prevent Pain After Third Molar (Wisdom Tooth) ExtractionCompletedPhase 2National Institute of Dental and Craniofacial Research (NIDCR)NCT00026819Written as Rofecoxib
- A Study to Evaluate Rofecoxib Versus Placebo and Diclofenac in Patients With Acute Painful Rotator Cuff SyndromeTerminatedPhase 3Merck Sharp & Dohme LLCNCT00140933Written as MK0966; rofecoxib
- An End to the Yom Kippur (and Ramadan) HeadacheCompletedNot applicableSheba Medical CenterNCT00263094Written as Rofecoxib
- Selective COX-II Inhibitor as a Palliative Therapy in Patients With R1 or R2 Resection for Disseminated Stomach Cancer - A Multi-Centre Prospective Randomized Controlled TrialStatus unknownPhase 3Chinese University of Hong KongNCT00165048Written as Vioxx (Rofecoxib)
See all 21 studies that test rofecoxib →
As the comparator · 3 — what is tested is compared with rofecoxib
- A Four-Week Study Comparing Acetaminophen Extended Release and Rofecoxib in the Treatment of Osteoarthritis of the KneeCompletedPhase 3Johnson & Johnson Consumer and Personal Products WorldwideNCT00568295Written as Rofecoxib
- Barrett's Esophagus - 315 - 3 Way Cross OverCompletedPhase 4AstraZenecaNCT00637988Written as Rofecoxib
- Safety of Lumiracoxib in Patients With OsteoarthritisCompletedPhase 3NovartisNCT00637949Written as rofecoxib
Codes
What other systems call rofecoxib · ClinicalTrials.gg INT004122
- MeSH (NLM) C116926rofecoxibConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 0QTW8Z7MCRROFECOXIBConfirmed FDA, NLM, Wikidata
- RxNorm 232158Confirmed FDA, Wikidata
- Wikidata Q411412rofecoxibConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1832RofecoxibOne source FDA
- DrugBank DB00533One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C116926 | rofecoxib | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 0QTW8Z7MCR | ROFECOXIB | Confirmed FDA, NLM, Wikidata |
| RxNorm | 232158 | — | Confirmed FDA, Wikidata |
| Wikidata | Q411412 | rofecoxib | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1832 | Rofecoxib | One source FDA |
| DrugBank | DB00533 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.